Global Embolization and Embolotherapy Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Embolization and Embolotherapy Market was valued at $4.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 8.1% CAGR, to an estimated market size of $6.6 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global embolization and embolotherapy market encompasses minimally invasive, image-guided medical procedures and the associated embolic agents and support devices used to intentionally block or reduce blood flow to specific anatomical regions. This therapeutic approach is primarily utilized to treat cancerous tumors (such as hepatocellular carcinoma), aneurysms, vascular malformations, and various hemorrhages, serving as a precise alternative to traditional open surgery.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Embolization and Embolotherapy Market in the period 2025-30:
- There is a significant global shift from traditional open vascular surgery toward minimally invasive catheter-based procedures to reduce recovery times and complications.
- The development of next-generation drug-eluting microspheres and radioactive Y-90 microspheres is enhancing precision in interventional oncology.
- Integration of artificial intelligence and advanced 3D imaging guidance is improving procedural accuracy and predictive modeling of embolization outcomes.
- Rising prevalence of liver cancer and renal cell carcinoma, particularly in emerging markets, is a primary driver for transarterial chemoembolization (TACE) adoption.
- The market is seeing an outpatient shift, with increasing procedure volumes moving to ambulatory surgical centers due to payer pressure and compact delivery systems.
- Increasing utilization of liquid embolic agents like Onyx for complex neurovascular and peripheral vascular occlusions is expanding the treatable patient pool.
- Strategic industry consolidation and M&A activity are allowing major players to offer comprehensive portfolios spanning embolic agents and microcatheter access tools.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Embolic Agents
- Support Devices
- Other Products